PURPOSE: To evaluate the cost-effectiveness of magnetic resonance (MR)
angiography in the preoperative planning of treatment in patients wit
h limb-threatening peripheral vascular disease (PVD). MATERIALS AND ME
THODS: A decision model was developed to study the effects of MR angio
graphy on the outcome and cost of treatment. The authors calculated th
e incremental cost per quality-adjusted life-years gained(ie, cost-eff
ectiveness ratio) when conventional angiography was replaced or supple
mented with MR angiography. Previously reported data regarding the acc
uracies of MR and conventional angiography were used in the analysis.
RESULTS: The cost-effectiveness ratio of MR angiography ranged from ne
gative (cost-reducing) values to $78,000. For the base case in which t
he sensitivity and specificity of MR angiography for the evaluation of
inflow vessels were 92% and 88% and those of conventional angiography
were 97% and 97%, respectively, the cost-effectiveness ratio was $25,
895. CONCLUSION: MR angiography may be a cost-effective alternative to
conventional angiography in patients with limb-threatening PVD if its
accuracy for the inflow evaluation reaches certain thresholds. Furthe
r prospective investigation is warranted.